PEN
Penumbra, Inc.
Medical Devices · Healthcare · United States
326.75
close · 2026-08-13
value
6
cheaper than peers6
quality
91
stronger fundamentals91
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 8.41× | 27 |
| forward P/E | 53.29× | 16 |
| price to sales | 8.39× | 12 |
| EV to EBITDA | 59.73× | 5 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 13.9% | 78 |
| return on equity | 11.4% | 75 |
| operating margin | 10.5% | 72 |
| revenue growth | 14.9% | 65 |
4 of 4 measures available
Facts
| market cap | $13B |
| free cash flow | — |
| employees | 4,700 |
| first trade | 2015-09-18 |
| next earnings | not reported |
| fundamentals updated | 2026-07-31 |